Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

June 22, 2021

Utilizing magnetic resonance techniques to study membrane interactions of amyloid peptides.

Biochemical Society Transactions
Sunnia RajputFrances Separovic
June 22, 2021

Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease.

ACS Chemical Neuroscience
Zhenquan XuanWei Cui
June 22, 2021

Identifying novel genetic variants for brain amyloid deposition: a genome-wide association study in the Korean population.

Alzheimer's Research & Therapy
Hang-Rai KimHee Jin Kim
June 22, 2021

ER stress associated TXNIP-NLRP3 inflammasome activation in hippocampus of human Alzheimer's disease.

Neurochemistry International
Saifudeen IsmaelTauheed Ishrat
June 22, 2021

Molecular insight into the early stage of amyloid-β(1-42) Homodimers aggregation influenced by histidine tautomerism.

International Journal of Biological Macromolecules
Abbas SalimiJin Yong Lee
June 21, 2021

Modeling structural interconversion in Alzheimers' amyloid beta peptide with classical and intrinsically disordered protein force fields.

Journal of Biomolecular Structure & Dynamics
Kingsley Y WuChia-En A Chang
June 21, 2021

Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer's Disease Model.

Journal of Alzheimer's Disease : JAD
Sara L PauloSara Xapelli
June 21, 2021

Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Shorena JanelidzeOskar Hansson
June 21, 2021
Open Access

Amyloid-β Impairs Dendritic Trafficking of Golgi-Like Organelles in the Early Phase Preceding Neurite Atrophy: Rescue by Mirtazapine.

Frontiers in Molecular Neuroscience
Elsa FabbrettiEnrico Tongiorgi
June 20, 2021

Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Xiaobing HuangGarry Wong
June 19, 2021

Amyloid-β (1-42) peptide induces rapid NMDA receptor-dependent alterations at glutamatergic synapses in the entorhinal cortex.

Neurobiology of Aging
Olayemi Joseph Olajide, Clifton Andrew Chapman
June 19, 2021

Ultrasmall Molybdenum Disulfide Quantum Dots Cage Alzheimer's Amyloid Beta to Restore Membrane Fluidity.

ACS Applied Materials & Interfaces
Yuhuan LiPu Chun Ke
June 18, 2021
Open Access

Lysosomal proteolysis of amyloid beta is impeded by fibrils grown in both acidic and neutral pH environments

BioRxiv : the Preprint Server for Biology
T. R. Lambeth, Ryan R. Julian
June 17, 2021
Open Access

Changes of plasma Aβ and t-tau along with 18F-florbetapir PET in a cohort of cognitive decline

Feng-Feng PanQihao Guo
June 17, 2021

Effects of Berberine on Diabetes and Cognitive Impairment in an Animal Model: The Mechanisms of Action.

The American Journal of Chinese Medicine
Jing-Hua ZhangHao Su

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved